Welcome to La Cebolla issue of M&A Daily.
Google (GOOG/GOOGL) and Sanofi (NYSE:SNY) notified the EU of their plans to collaborate on new ways to monitor and treat diabetes. Antitrust approval for the joint venture is expected in February. This is a new priority for Google founders Larry Page and Sergey Brin.
Google is developing a contact lens that measures the glucose level in tears without the need for a painful, inconvenient, and expensive blood test.
Diabetes is a main focus of Alphabet's Verily Life Sciences. They are also working with Novartis (NYSE:NVS) and DexCom (NASDAQ:DXCM) on this issue. Other projects include working with Biogen (NASDAQ:BIIB) on MS, AstraZeneca (NYSE:AZN) on heart disease, and Johnson & Johnson (NYSE:JNJ) on surgical robots.
Univision (Pending:UVN) is buying a controlling stake in parody site The Onion. The Onion has recently written about companies from Coca-Cola (NYSE:KO), to Walgreens (NASDAQ:WBA), SeaWorld (NYSE:SEAS), and CVS (NYSE:CVS).
MedAssets (NASDAQ:MDAS) has accelerated commitments for its $1.13 billion debt issuance by one day to January 20th. Pamplona announced the CEO and executive team following the deal's close.
Harrison Street and Campus Crest (NYSE:CCG) filed a memorandum of understanding for their settlement of the nuisance shareholder suit.
Time Warner Cable
The FCC is set to restart the clock on its review of the Charter (NASDAQ:CHTR) acquisition of Time Warner Cable (TWC).
I hope that your clocks work better than the FCC's.
Greenlight bought a new position in Macy's (NYSE:M). Greenlight's David Einhorn favors private equity joining with a REIT to take it private and unlock the real estate value. More to come in future editions of M&A Daily…
Elsewhere on Seeking Alpha
- Buy Retail Holdings At An Effective Discount Of 60%
- 16% Absolute Return From Marriott's Acquisition Of Starwood
- In A Market Collapse, Where Are The Bargains?
Disclosure: I am/we are long MEG, FCS, TWC, M.
I wrote this article myself, and it expresses my own opinions. I am not receiving compensation for it (other than from Seeking Alpha). I have no business relationship with any company whose stock is mentioned in this article.
Additional disclosure: Chris DeMuth Jr and Andrew Walker are portfolio managers at Rangeley Capital. Rangeley invests with a margin of safety by buying securities at deep discounts to their intrinsic value and unlocking that value through corporate events. In order to maximize total returns for our investors, we reserve the right to make investment decisions regarding any security without further notification except where such notification is required by law.
Editor's Note: This article discusses one or more securities that do not trade on a major U.S. exchange. Please be aware of the risks associated with these stocks.